Last updated on April 17, 2014 at 21:23 EDT

Latest Pulmo BioTech Stories

2008-07-08 09:00:17

Pulmo BioTech has announced that its subsidiary, PulmoScience has completed the bio-distribution studies on its DFH-12 product candidate for the PulmoBind technology of molecular imaging of the vascular system of the lungs. The in- vivo studies have shown that the molecule is predominantly retained in the lungs 30 minutes after injection with only minor retention in the liver and heart. Further bio-distribution studies have also shown that after 240 minutes the majority of the injected...